Elite Trades From Anywhere

$100 Off Your First Year

00
Days
00
Hours
00
Mins
00
Sec
Claim Now
Jul 01, 7:40 AMBarclays reiterates Equal Weight on Zoetis, slashes price target to $85 from $136
Index
S&P 500
Market Cap
31.36B
Enterprise Value
38.66B
Income
2.64B
Sales
9.51B
Book/sh
7.69
Cash/sh
4.63
Employees
14500
IPO
Feb 01, 2013
P/E
12.39
Forward P/E
10.15
PEG
1.33
P/S
3.30
P/B
9.73
P/C
16.16
P/FCF
14.68
EV/EBITDA
9.52
EV/Sales
4.07
Quick Ratio
1.91
Current Ratio
3.15
Debt/Eq
2.86
LT Debt/Eq
2.86
Option/Short
Yes / Yes
EPS (ttm)
6.04
EPS next Y
7.37
EPS next Q
1.86
EPS this Y
7.47%
EPS next Y
7.00%
EPS next 5Y
7.62%
EPS past 3/5Y
10.25% 11.96%
Sales past 3/5Y
5.42% 7.24%
EPS Y/Y TTM
8.35%
Sales Y/Y TTM
2.40%
EPS Q/Q
1.02%
Sales Q/Q
1.89%
Insider Own
0.57%
Insider Trans
-0.35%
Inst Own
102.18%
Inst Trans
-0.53%
ROA
18.07%
ROE
67.01%
ROIC
21.19%
Gross Margin
70.43%
Oper. Margin
37.57%
Profit Margin
27.79%
SMA20
-3.77%
SMA50
-13.26%
SMA200
-36.25%
Trades
Shs Outstand
420.35M
Shs Float
416.83M
52W High
161.77 -53.76%
52W Low
71.47 4.66%
Volatility
3.47% 3.25%
ATR (14)
2.79
RSI (14)
38.92
Beta
0.74
Rel Volume
0.63
Avg Volume
6.83M
Volume
4,334,960
Perf Week
-3.88%
Perf Month
-2.08%
Perf Quarter
-36.23%
Perf Half Y
-40.83%
Perf YTD
-40.55%
Perf Year
-52.98%
Perf 3Y
-56.56%
Perf 5Y
-61.18%
Perf 10Y
57.64%
Prev Close
72.45
Price
74.80
Change
3.24%
Date Action Analyst Rating Change Price Target Change
May-27-26Downgrade Argus Buy → Hold
Apr-15-26Initiated Citigroup Buy $145
Jan-22-26Downgrade Piper Sandler Overweight → Neutral $135
Dec-15-25Downgrade BofA Securities Buy → Neutral $135
Dec-09-25Initiated Barclays Equal Weight $136
Nov-21-25Initiated KeyBanc Capital Markets Sector Weight
Jul-17-25Downgrade Leerink Partners Outperform → Market Perform $155
Jun-18-25Downgrade Stifel Buy → Hold $160
Dec-02-24Initiated Leerink Partners Outperform $215
Jul-25-24Initiated BTIG Research Buy $220
Jul-01-26 06:59AM
Jun-27-26 08:55PM
Jun-25-26 08:30AM
04:59AM
Jun-15-26 02:36AM
03:27AM Loading…
Jun-11-26 03:27AM
Jun-04-26 10:23AM
Jun-03-26 02:57AM
May-27-26 09:35AM
May-21-26 08:30AM
May-20-26 04:15PM
May-11-26 04:30PM
May-07-26 08:45PM
04:30PM
12:09PM
11:47AM Loading…
11:47AM
07:59AM
07:59AM
07:08AM
07:00AM
Apr-16-26 09:47AM
Apr-15-26 09:47AM
Apr-02-26 08:30AM
Mar-23-26 01:38PM
Mar-16-26 04:19AM
Mar-14-26 02:49PM
Mar-12-26 08:30AM
Mar-06-26 09:40AM
09:30AM
07:54AM
08:30AM Loading…
Mar-05-26 08:30AM
Mar-02-26 07:00AM
04:07AM
Mar-01-26 05:06AM
Feb-27-26 04:51PM
11:00AM
05:29AM
Feb-26-26 11:03PM
Feb-24-26 04:22PM
09:50AM
08:30AM
Feb-23-26 10:57AM
Feb-19-26 12:38AM
Feb-18-26 10:05AM
09:40AM
04:01AM
Feb-13-26 04:57PM
07:13AM
12:35AM
Feb-12-26 04:15PM
04:05PM
01:24PM
12:32PM
10:30AM
09:30AM
08:45AM
08:10AM
07:46AM
07:38AM
07:05AM
07:00AM
05:36AM
04:50AM
Feb-10-26 10:09PM
10:00AM
Feb-09-26 11:30AM
10:22AM
09:15AM
08:55AM
Feb-06-26 08:57AM
Feb-05-26 04:15PM
12:22PM
10:00AM
09:50AM
Feb-04-26 02:18PM
Feb-03-26 06:15PM
11:40AM
10:00AM
09:45AM
08:14AM
Jan-31-26 12:35PM
Jan-30-26 09:40AM
Jan-28-26 06:15PM
Jan-27-26 04:04PM
08:55AM
Jan-26-26 04:27PM
Jan-23-26 09:41AM
Jan-22-26 01:25PM
12:20PM
12:10PM
09:37AM
08:55AM
Jan-20-26 10:35PM
Jan-16-26 09:25AM
Jan-12-26 06:15PM
04:52PM
09:22AM
Jan-07-26 02:11PM
11:40AM
Dec-31-25 09:15AM
Zoetis, Inc. engages in the discovery, development, manufacture, and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic tests, and precision animal health technology. It operates through the United States and International geographical segments. The company was founded in 1952 and is headquartered in Parsippany, NJ.
CEO & DirectorMs. Kristin C. Peck
Executive VP & CFOMr. Wetteny N. Joseph CPA
Executive VPMs. Roxanne Lagano
Scientific AdvisorDr. Robert J. Polzer Ph.D.
Executive VP & Chief Commercial OfficerMr. Jamie Brannan
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
DAMELIO FRANK ADirectorMay 13 '26Buy75.396,650501,34421,458May 13 04:35 PM
Bisaro PaulDirectorMay 13 '26Buy75.882,000151,75027,862May 13 04:35 PM
MCCALLISTER MICHAEL BDirectorMay 11 '26Buy77.763,000233,27324,524May 12 07:26 PM
PECK KRISTIN CChief Executive OfficerFeb 17 '26Option Exercise41.8320,000836,600121,337Feb 17 04:22 PM
PECK KRISTIN CChief Executive OfficerFeb 17 '26Sale127.0520,0002,540,964101,337Feb 17 04:22 PM
Polzer Robert JOfficerFeb 17 '26Proposed Sale127.342,346298,742Feb 17 04:14 PM
PECK KRISTIN COfficerFeb 17 '26Proposed Sale127.0520,0002,540,964Feb 17 04:13 PM
Polzer Robert JOfficerFeb 13 '26Proposed Sale129.093,662472,728Feb 13 04:26 PM